Implandata launches EYEMATE IOP-Tracking Service for remote monitoring and improved glaucoma care

7 Jun 2020
Edward Carter
Publishing / Media

Product news

Implandata Ophthalmic Products GmbH have announced the launch of the web-based EYEMATE IOP-Tracking Service for remote monitoring and management of glaucoma care. The EYEMATE IOP-Tracking Service is the world’s first solution to provide eye doctors with Intra-Ocular Pressure (IOP) measurements collected 24/7/365 under patients’ normal life conditions.

Prof. Kaweh Mansouri, MD, Ophthalmologist at Clinique de Montchoisi Lausanne/Switzerland and Chief Medical Officer of Implandata explains: “Remote IOP monitoring provides immediate alert in case the therapy needs to be adjusted, without requiring an office visit. This is vital for controlling glaucoma, because IOP fluctuates continually without patients noticing it. The need for remote monitoring is even greater during stay-at-home orders, as we’re experiencing due to COVID-19; we can ensure that glaucoma care is well managed, without putting patients at risk.”

Prof. Robert N. Weinreb MD, Chair and Distinguished Professor of Ophthalmology at the University of California, San Diego states: "Remote monitoring of IOP will transform glaucoma care. The availability of large amounts of real-life IOP data will enable personalized glaucoma management to prevent vision loss."

CEO Max Ostermeier emphasizes: “We are committed to patients’ well-being. The EYEMATE system is backed by ten years of clinical data, which means the safety and utility are proven.” He adds, “In past years, increasing numbers of glaucoma patients have called us. They’re worried about losing their eyesight and looking for a way to control their disease. The current pandemic further increases the need for digital health and remote monitoring solutions.”

The CE-marked EYEMATE system is now offered to patients by leading eye centers in Germany, Switzerland and the UK. Further eye clinics are on the EYEMATE waiting list. The FDA “Breakthrough Device” approval process has been started, in preparation for launching the EYEMATE system in the USA.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Cancer DiagnosticsThere are a wide variety of diagnostic tests for cancer available, and this range continues to expand as our knowledge of cancer improves. Current diagnostic methods include biopsy, imaging and blood tests for known biomarkers. New methods in research development include liquid biopsies and cancer breathalyzers.CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.